Drug Design with Advanced Computational Strategies and Artificial Intelligence
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Chemical Biology".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 23264
Special Issue Editors
Interests: molecular modeling based drug discovery; artificial Intelligence (AI) based drug discovery; computer-aided drug design
Interests: molecular simulation in drug design; computer-aided drug design methods; small molecule inhibitors; drug design; virtual screening; biological evaluation
Special Issue Information
Dear Colleagues,
Theoretical computation methods represented by various artificial intelligence algorithms have greatly improved the efficiency of drug development, and they are playing an increasingly important role in the entire process of drug design campaign, including target identification, hit compound discovery/optimization, lead compound optimization (for better ADMET properties), etc. Here, we launch a new Special Issue, “Drug Design with Advanced Computational Algorithms and Artificial Intelligence”, to promote the rational application of theoretical computation methods in drug design. This Special Issue welcomes studies including, but not limited to, drug design/discovery based on artificial intelligence, machine learning and binding free energy calculation. In addition, mechanism exploration/analysis for understanding drug–target interactions and associated topics are also welcome.
Dr. Huiyong Sun
Dr. Peichen Pan
Dr. Jingyu Zhu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- machine learning
- artificial intelligence
- binding free energy calculation
- scoring function
- drug design/discovery
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.